glp 1 cigna will stop covering GLP-1 weight-loss drugs including Wegovy and Zepbound in its employee health plan effective July 1, according to Reuters Cigna prior authorization for Ozempic,
Description
The abdomen is typically the best starting site at higher body weights

He is Senior Group Leader at the Novo Nordisk Foundation Center for Basic Metabolic Research, Copenhagen

Accessed March 13, 2026
Beyond the numbers on the scale, these stories highlight positive shifts in various aspects of their lives

You may have other medical problems that are not being addressed because obesity causes multiple organ problems
